下肢难治性骨折相关感染中18F-氟脱氧葡萄糖正电子发射断层显像/CT作用的真实世界经验:一项回顾性诊断研究
本回顾性诊断研究纳入2016年11月至2021年10月在一家三级骨科中心完成的429例次PET/CT扫描,评估18F-FDG PET/CT对下肢难治性骨折相关感染(FRI)的诊断准确性并分析最佳SUVmax阈值及亚组诊断表现。总体AUC为0.84,最佳SUVmax阈值为4.75,灵敏度70.7%、特异度85.6%;按症状表现和距前次手术间隔分层设定阈值可改善诊断准确性。
要点
- 18F-FDG PET/CT诊断下肢难治性FRI的总体AUC为0.84,最佳SUVmax阈值4.75时灵敏度70.7%、特异度85.6%。
- 「无体征+早期」组在阈值5.05时准确性最高(87.5%)、特异度89.4%。
- 「无体征+过度期」组阈值3.95可减少过度诊断;「过度期」组阈值4.65时特异度最高(90.1%)但假阳性率也最高(42.45%)。
核心结论
- 18F-FDG PET/CT是诊断难治性FRI的可靠工具,按距前次手术时间和症状表现分层设定SUVmax阈值可提高诊断准确性。
- 尽管PET/CT初始成本高,但通过改善感染管理和降低复发率,其长期具有成本效益。
研究设计与样本
- 回顾性诊断研究,纳入2016年11月至2021年10月在一家三级骨科中心完成的429例次PET/CT扫描。
- 纳入疑似难治性FRI患者,定义为至少两次先前治疗后感染持续存在。
- 参考标准结合术中所见、组织学分析、微生物培养和随访数据。
- 采用受试者工作特征曲线分析计算灵敏度、特异度和曲线下面积(AUC)等诊断性能指标。
- 亚组分析按症状表现和距前次手术间隔对患者进行分层。
主要发现
- PET/CT总体AUC为0.84。
- 最佳SUVmax阈值为4.75,灵敏度70.7%、特异度85.6%。
- 「无体征+早期」组在阈值5.05时准确性最高(87.5%)、特异度89.4%。
- 「无体征+过度期」组采用更严格阈值3.95以减少过度诊断,区分残留代谢活动与感染。
- 「过度期」组在阈值4.65时特异度最高(90.1%),但假阳性率也最高(42.45%)。
关键数值与推荐
- 总体最佳SUVmax阈值为4.75,对应灵敏度70.7%、特异度85.6%、AUC 0.84。
- 「无体征+早期」组阈值5.05,准确性87.5%、特异度89.4%。
- 「无体征+过度期」组阈值3.95。
- 「过度期」组阈值4.65,特异度90.1%、假阳性率42.45%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study aims to evaluates the diagnostic accuracy of 18F-FDG positron emission tomography (PET)/CT for refractory fracture-related infections (FRIs) in the lower limbs, identifying optimal maximum standardized uptake value (SUVmax) thresholds and analyzing sub-group-specific diagnostic performance. METHODS: This retrospective study included 429 PET/CT scans performed between November 2016 and October 2021 at a tertiary orthopaedic centre. Patients with suspected refractory FRI, characterized by infection persisting after at least two prior treatments, were included. The reference standard combined intraoperative findings, histological analysis, microbiological cultures, and follow-up data. Diagnostic performance metrics, including sensitivity, specificity, and area under the curve (AUC), were calculated using receiver operating characteristic curve analysis. Sub-group analyses stratified patients based on symptomatic presentation and the interval since previous surgery. RESULTS: PET/CT demonstrated robust diagnostic performance with an overall AUC of 0.84. The optimal SUVmax threshold was 4.75, yielding sensitivity of 70.7% and specificity of 85.6%. Sub-group analyses revealed that tailored thresholds improved diagnostic accuracy, with the 'No signs + Early phase' group achieving the highest accuracy (87.5%) and specificity (89.4%) at a threshold of 5.05. Conversely, a stricter cut-off of 3.95 in the 'No signs + Over phase' group minimized overdiagnosis by distinguishing residual metabolic activity from infection. The 'Over phase' group exhibited the highest specificity (90.1%) at a cut-off of 4.65 but also the highest false-positive rate (42.45%), reflecting the challenges of diagnosing chronic infections. These findings emphasize the variability in SUVmax thresholds across different clinical settings. CONCLUSION: 18F-FDG PET/CT is a reliable diagnostic tool for refractory FRI, with stratified SUVmax thresholds improving diagnostic accuracy based on the time since previous surgery and symptom presentation. Despite its high initial cost, PET/CT demonstrates long-term cost-effectiveness by improving infection management and reducing recurrence rates.
引用
- Cai W, Lu Y, Ren Z, et al. Real-world experience of the role of 18F-fluorodeoxyglucose positron emission tomography/CT refractory fracture-related infection on lower limbs : a retrospective diagnostic study. Bone Joint J. 2025. PMID: 40746114. doi:10.1302/0301-620X.107B8.BJJ-2024-1158.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。